[1]闵锐.辐射损伤防护药及细胞因子治疗研究动态[J].国际放射医学核医学杂志,2004,28(4):173-178.
 MIN Rui.Status of the research on radioprotective drugs and treatment of radiation damage by cytokines[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):173-178.
点击复制

辐射损伤防护药及细胞因子治疗研究动态(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
28
期数:
2004年第4期
页码:
173-178
栏目:
放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
Status of the research on radioprotective drugs and treatment of radiation damage by cytokines
作者:
闵锐
200433 上海, 第二军医大学放射医学教研室
Author(s):
MIN Rui
Department of Radiation Medicine, Second Military Medical University, Shanghai 200433, China
关键词:
辐射损伤辐射防护药细胞因子
Keywords:
radiation damageradioprotective drugcytokine
分类号:
R818.052+.5;R979.6
摘要:
硝基氧、氨磷汀和甾族类化合物是目前较受关注的防护辐射损伤的候选药,其中氨磷汀1999年已被美国FDA(食品与药物管理局)批准为放射治疗的辐射防护药。辐射损伤的细胞因子治疗已由过去单一造血细胞刺激因子的使用发展到针对多种造血细胞以及与造血及免疫细胞生长发育有关的微环境的不同功能因子的组合使用,大大改善了大剂量辐射损伤治疗的效果。
Abstract:
Nitroxide, amifostine and steroids are most considered as candidates of radioprotective drug. Amifostine is the first radioprotective drug used in radiotherapy approved by FDA(Food and Drug Administration)of USA in 1999. The use of the cytokine in treatment of the radiation damage has been developed from single cytokine which just stimulates one cell population to the combination of cytokines which function as both hematopoitic cells and hematopoitic microenvironment. Therapeutic effect of radiation damage has been significantly improved by use of cytokine combination.

参考文献/References:

1 Xavier S,Yamada K,Samuni AM,et al.Differential protection by nitroides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage[J].Biochim Biophys Acta,2002,1573(2):109-120.
2 Samuni A,Goldstein S, Russo A, et al.Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines[J].J Am Chem Soc,2002,24(29):8719-8724.
3 Mitchell JB and Krishna MC.Nitroxides as radiation protectors[J].Mil Med,2002,167(1 suppl):49-50.
4 Brizel DM,Wasserman TH,Henke M,et al.Phase III randomized trial of amifostine as a radioprotector in head and neck cancer[J].J Clin Oncol,2000,18(19):3339-3345.
5 Rades D,Fehlauer F,Bajrovic A,et al.Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients[J].Radiother Oncol,2004,70(3):261-264.
6 Komaki R,Lee JS,Milas L,et al.Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer:report of a randomized comparative trial[J].Int J Radiat Oncol,Biol,Phys,2004,58(5):1369-1377.
7 Pamujula S,Graves RA,Kishore V,et al.Preparation and in vitro characterization of amifostine of biodegradable microcapsules[J].Eur J Pharm Biopharm,2004,;7(2):213-218.
8 Grdina DJ,Murley JS and Kataoka Y.Radioprotectants:current status and new direction[J]. Oncology,2002,63(2 suppl):2-10.
9 Grdina DJ,Murley JS,Kataoka Y,et al.Relationship between cyto-protection and mutation prevention by WR1065[J].Mil Med,2002,167(1 suppl):51-53.
10 Loria RM. Immune up-regulation and apoptosis by androstene steroids[J].Steroids,2002,67(12):953-966.
11 Whitnall MH,Elliott TB,Landauer MR,et al.Protection againstgamma-irradiation with 5-androstenediol[J].Mil Med,2002,167(2 suppl):64-65.
12 Whitnall MH,Inal CE,Jackson WE 3rd,et al.In vivo radioprotection by 5-androstenediol:stimulation of the innate immune system[J].Radiat Res,2001,156(3):283-293.
13 Whitnall MH,Wilhelmesn CL,Mckinney L,et al.Radioprotectrive efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice[J].Immunophamacol Immunotoxicol,2002,24(4):595-626.
14 Fry SA,Neta R,Weiss JF,et al.Prevention and treatment:summary statememt[J].Mil Med,2002,167(1 suppl):87-93.
15 Fry TJ,Moniuszko M,Creekmore S,et al.IL-7 therapy dramatically alters peripheral T cell homeostasis in normal and SIV-infected nonhuman primates[J].Blood,2003,101(6):2294-2299.
16 Storek J,Gillespy T,Lu H,et al.Interleukin-7 improves CD4 T cell constitution after autologous CD34 cell transplantation in monkeys[J].Blood,2003,101(10):4209-4218.
17 Sinha ML,Fry TJ,Fowler DH,et al.Interleukin 7 worsens graft-ver-sus-host disease[J].Blood,2002,100(7):2642-2649.
18 Alpdogan O,Muriglan SJ,Eng JM,et al.IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation[J].J Clin Invest,2003,112(7):1095-1107.
19 Min D,Taylor PA,Panoskaltsis-Mortari A,et al.Protection from thymic epithelial cell injury by keratinocyte growth factor:a new approach to improve thymic and peripheral T cell reconstitution after bone marrow transplantation[J].Blood,2002,99(12):4592-4600.
20 Terry NH,Brinkley J,Doig AJ,et al.Cellular kinetics of murine lung:model system to determine basis for radioprotection with ker-atinocyte growth factor[J].Int J Radiat Oncol Biol Phys,2004,;8(2):435-444.
21 Hille A,Rave-Frank M,Pradier O,et al.Effect of keratinocyte growth factor on the proliferation,clonogenic capacity and colony size of human epithelical tumor cells in vitro[J].Int J Radiat Biol,2003,79(2):119-128.
22 Panoskaltsis-Mortari A,Ingbar DH,Jung P,et al.KGF pretreatment decreases B7 and granzyme B expression and hostens repair in lung of mice after allogeneic BMT[J].Am J Physiol Lung Cell Mol Physiol,2000,278(5):L988-L999.
23 Dainiak N,Waselenko JK,Armitage JO,et al.The hematologist and radiation casualties.[J].Hematology (Am Soc Hematol Educ Program),2003,473-496.
24 Westermann J,Nguyen-Hoai T,Mollweide A, et al.Flt-3 ligand as adjuvant for DNA vaccination angments immune reponses but dose not skew TH1/TH2 polarization[J].Gene Therapy,2004,11(13):1048-1056.
25 Drouet M,Mourcin F,Grenier N,et al.Single administration of stem cell factor,Flt-3 ligand,megakaryocyte growth and development factor,and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J].Blood,2004,103(3):878-885.
26 Linard C,Marquette C,Mathieu J,et al.Acute induction of inflammatory cytokine expression after gamma irradiation in the rat:effect of an NF-kappaB inhibitor[J].Int J Radiat Oncol Biophys,2004,58(2):427-434.
27 Egan LJ,Eckmann L,Greten FR,et al.I (kappa)B-kinase (beta)-dependent NF-(kappa)B activation provides radioprotection to the intestinal epithelium[J].Proc Natl Acad Sci USA,2004,101(8):2452-2457.
28 Herodin F,Bourin P,Mayol JF,et al.Short-term injection of anti-apoptotic cytokine combinations soon after lethal g irradiation promotes survival[J].Blood,2003,101(7):2609-2616.

相似文献/References:

[1]包明月,刘玉龙.应用间充质干细胞治疗急性辐射损伤的研究现状与进展[J].国际放射医学核医学杂志,2016,40(1):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
 Bao Mingyue,Liu Yulong.Recent advances in the application of mesenchymal stem cells for treatment of acute radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):65.[doi:10.3760/cma.j.issn.1673-4114.2016.01.013]
[2]贺欣,储小飞,罗丹,等.穿心莲药物对辐射损伤效应影响的初步研究[J].国际放射医学核医学杂志,2015,39(5):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
 he xin,chu xiaofei,luo dan,et al.exploration of andrographolide effects on radiation injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):375.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 005]
[3]路璐,张俊伶,李德冠,等.6 gy 137cs γ射线照射对小鼠造血功能损伤的动态观察研究[J].国际放射医学核医学杂志,2015,39(5):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
 lu lu*,zhang junling,li deguan,et al.effects of 6 gy 137cs γ-irradiattion on the hematopoietic system of mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):393.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 009]
[4]刘惠惠,李险峰.放射性心脏损伤诊断和防治的临床研究进展[J].国际放射医学核医学杂志,2016,40(5):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
 Liu Huihui,Li Xianfeng.Clinical research progress in diagnosis,prevention and treatment of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):374.[doi:10.3760/cma.j.issn.1673-4114.2016.05.008]
[5]张倩如,李海涛,田红旗.小分子辐射防护药物的研究进展[J].国际放射医学核医学杂志,2016,40(5):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
 Zhang Qianru,Li Haitao,Tian Hongqi.Small molecule compounds against radiation:research advances[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):394.[doi:10.3760/cma.j.issn.1673-4114.2016.05.012]
[6]王浩,沈秀,靳瑾,等.“四物汤”对辐射危害的辅助保护作用研究[J].国际放射医学核医学杂志,2015,39(2):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
 Wang Hao,Shen Xiu,Jin Jin,et al.Protective activity of Siwu Decoction against radiation hazards[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):121.[doi:10.3760/cma.j.issn.1673-4114.2015.02.004]
[7]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
 Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[8]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
 Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[9]李德冠,路璐,吴红英,等.G-CSF联合SB203580对4Gy照射小鼠免疫系统的作用[J].国际放射医学核医学杂志,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
 Li Deguan,Lu Lu,Wu Hongying,et al.The effects of G-CSF combined with SB203580 on the immune system of mice received 4 Gy total body irradiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):216.[doi:10.3760/cma.j.issn.1673-4114.2014.04.002]
[10]张洪明,李险峰.放射性心脏损伤动物模型的研究进展[J].国际放射医学核医学杂志,2014,38(6):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]
 Zhang Hong-ming,Li Xian-feng.Progress in animal model of radiation-induced heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):412.[doi:10.3760/cma.j.issn.1673-4114.2014.06.015]

备注/Memo

备注/Memo:
收稿日期:2004-05-23。
更新日期/Last Update: 1900-01-01